201 reports of this reaction
1.0% of all SULFUR reports
#19 most reported adverse reaction
RASH MACULAR is the #19 most commonly reported adverse reaction for SULFUR, manufactured by Alchemee, LLC. There are 201 FDA adverse event reports linking SULFUR to RASH MACULAR. This represents approximately 1.0% of all 20,945 adverse event reports for this drug.
Patients taking SULFUR who experience rash macular should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RASH MACULAR is a less commonly reported adverse event for SULFUR, but still significant enough to appear in the safety profile.
In addition to rash macular, the following adverse reactions have been reported for SULFUR:
The following drugs have also been linked to rash macular in FDA adverse event reports:
RASH MACULAR has been reported as an adverse event in 201 FDA reports for SULFUR. This does not prove causation, but indicates an association observed in post-market surveillance data.
RASH MACULAR accounts for approximately 1.0% of all adverse event reports for SULFUR, making it a notable side effect.
If you experience rash macular while taking SULFUR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.